A comprehensive view of U.S. District Court. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Printing & Publishing Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

UroGen Pharma files lawsuit against Teva Pharmaceuticals in Delaware District Court for alleged patent infringement related to UroGen's cancer drug, JELMYTO, following Teva's attempt to seek FDA approval for a generic version of the drug
Published: April 04, 2024 by Associated Press
Medtronic advances patent infringement lawsuit against Axonics over SNM technologies, following Patent Trial and Appeal Board’s affirmation of claims validity in favor of Medtronic; company seeks lifting of stay on lawsuit in California court
Published: March 21, 2024 by Canada Newswire
U.S. District Court invalidates Teva's patent claims for methods for treating headaches, citing lack of description, awards Eli Lilly's post-trial motion for judgment; ruling overturns jury's previous US$176.0M verdict in favor of Teva
Published: March 13, 2024 by Mondaq Business Briefing
Court upholds Arkansas' 340B Drug Pricing Nondiscrimination Act against constitutional challenge by Pharmaceutical Research and Manufacturers of America; court rules the Federal Food, Drug, and Cosmetic Act does not preempt the state law
Published: March 12, 2024 by The American Hospital Association (AHA)
Federal judge rejects AstraZeneca's lawsuit against Medicare drug price negotiations; the ruling echoes a recent Ohio court’s decision that participation in the Inflation Reduction Act program is voluntary for drug manufacturers
Published: March 04, 2024 by Inside Health Policy

Ask us about our Printing & Publishing market view

Trending Chart

Interactive chart with headline count